Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Obesity

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...

Binge Eating Disorders

Binge Eating Disorders

Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Type II Diabetes I: Introduction

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

Hyperthyroidism II: Pathophysiology

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...

Hypothyroidism II: Pathophysiology

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Corporate Vectors of Chronic Disease - Using Internal Industry Documents to Craft Counterstrategies.

The New England journal of medicine·2026

Same author

Personalized Nutrition in Pediatric Chronic Diseases.

Metabolites·2025

Same author

The battle over "food addiction".

Frontiers in psychiatry·2025

Same author

Reappraisal of adverse obstetric outcomes independently associated with contemporary fertility treatment practices: a US prospective cohort study.

American journal of obstetrics and gynecology·2025

Same author

Analysis of Tanner stage in children conceived after the diagnosis of infertility: the DESCRT study.

Journal of assisted reproduction and genetics·2025

Same author

Felix A. Conte, MD, 1935-2024: The Endocrinologist's Endocrinologist.

Hormone research in paediatrics·2025

Same journal

Letters to the Editor: Why are Children with Klinefelter Syndrome Tall?

Pediatric endocrinology reviews : PER·2020

Same journal

Genetic and Environmental Factors in the Pathophysiology of Hashimoto's Thyroiditis.

Pediatric endocrinology reviews : PER·2020

Same journal

New Insights into Pheochromocytoma Biology: the Role of the Insulin - Like Growth Factor 1 (IGF1) System.

Pediatric endocrinology reviews : PER·2020

Same journal

Use of Growth Hormone Treatment in Skeletal Dysplasia - A Review.

Pediatric endocrinology reviews : PER·2020

Same journal

Dysostosis Multiplex in Human Mucopolysaccharidosis Type 1 H and in Animal Models of the Disease.

Pediatric endocrinology reviews : PER·2020

Same journal

Impact of Childhood Obesity on Bone Metabolism.

Pediatric endocrinology reviews : PER·2020

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 25, 2026

Multidisciplinary Approach to Obesity Management: A Case Report

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Hypothalamic obesity: causes, consequences, treatment.

Robert H Lustig¹

¹Division of Endocrinology, University of California San Francisco, CA 94143-0434, USA. rlustig@peds.ucsf.edu

Pediatric Endocrinology Reviews : PER

|February 10, 2009

Summary

This summary is machine-generated.

Hypothalamic obesity causes intractable weight gain due to hypothalamic damage, rendering lifestyle changes ineffective. This condition results from impaired hormonal signaling, leading to a starvation state and reduced energy expenditure.

More Related Videos

An Acupoint Catgut-embedding Therapy for Treating Obesity

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats

Published on: April 28, 2023

Related Experiment Videos

Last Updated: Jun 25, 2026

Multidisciplinary Approach to Obesity Management: A Case Report

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

An Acupoint Catgut-embedding Therapy for Treating Obesity

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats

Published on: April 28, 2023

Area of Science:

Neuroendocrinology
Obesity Research
Clinical Neurology

Background:

Hypothalamic obesity is a severe complication following central nervous system (CNS) injury.
It is characterized by intractable weight gain resistant to caloric restriction and lifestyle modifications.
The condition arises from a failure to process hormonal signals related to body fat.

Purpose of the Study:

To describe the pathophysiology of hypothalamic obesity.
To review current and emerging treatment strategies.
To emphasize the need for early and intensive management.

Main Methods:

Review of existing literature on hypothalamic obesity.
Analysis of hormonal signaling pathways involved.
Evaluation of pharmacological and surgical interventions.

Main Results:

Pathogenesis involves impaired transduction of adiposity signals, mimicking CNS starvation.
Reduced sympathetic activity leads to malaise and decreased energy expenditure.
Increased vagal activity promotes insulin secretion and fat storage.

Conclusions:

Pharmacological treatments include adrenergic agents and octreotide to suppress insulin.
Bariatric surgery has shown variable success.
Early and intensive management is crucial to combat hypothalamic obesity and its sequelae.